^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Thyroid Gland Hurthle Cell Carcinoma
    Drug:Prolia (denosumab) (RANK ligand inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Hurthle cell cancer: Bone metastases…Consider intravenous bisphosphonate or denosumab...